https://www.selleckchem.com/products/bms-1166.html
001). EQ-5D VAS was significantly lower (P = .011) in CRSsNP (mean 68.9) compared to CRSwNP (mean 73.2). However, CRSwNP patients reported significantly less symptom control, compared to CRSsNP, in association with nasal and emotional symptoms. Conclusion CRSwNP and CRSsNP have differences in symptom profile, effect on health-related QOL, and patient-perceived symptom control. CRSsNP experience significantly greater burden of ear/facial discomfort, while CRSwNP report greater hyposmia. Although CRSsNP reports lower general health-relat